| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
9,871 |
8,230 |
$3.45M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
14,313 |
12,738 |
$3.16M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
4,663 |
3,568 |
$1.93M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,491 |
1,180 |
$1.19M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
3,898 |
3,693 |
$413K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
10,221 |
2,491 |
$399K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,584 |
1,278 |
$276K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
443 |
368 |
$227K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
243 |
215 |
$161K |
| T1015 |
Clinic visit/encounter, all-inclusive |
720 |
615 |
$131K |
| 80053 |
Comprehensive metabolic panel |
14,345 |
11,526 |
$120K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,174 |
1,087 |
$99K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
171 |
132 |
$86K |
| 71046 |
Radiologic examination, chest; 2 views |
2,722 |
2,162 |
$76K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
2,320 |
1,019 |
$56K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,179 |
1,904 |
$55K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
395 |
361 |
$44K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
4,852 |
2,506 |
$42K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
294 |
275 |
$28K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
3,037 |
2,671 |
$22K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
302 |
115 |
$20K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
194 |
163 |
$20K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
101 |
90 |
$16K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
1,020 |
332 |
$16K |
| 72110 |
|
68 |
67 |
$13K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
2,105 |
612 |
$12K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
14 |
13 |
$12K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,622 |
1,375 |
$11K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
420 |
359 |
$9K |
| 73630 |
|
250 |
210 |
$7K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,677 |
1,925 |
$7K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,783 |
2,371 |
$7K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
16,597 |
12,771 |
$6K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
6,123 |
4,410 |
$6K |
| 87631 |
|
1,637 |
1,424 |
$6K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,755 |
2,344 |
$5K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,086 |
874 |
$5K |
| 73562 |
|
134 |
112 |
$5K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
4,111 |
3,362 |
$5K |
| 0012A |
|
119 |
113 |
$5K |
| 73030 |
|
157 |
121 |
$5K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
822 |
715 |
$4K |
| 0011A |
|
128 |
118 |
$4K |
| 84439 |
|
683 |
634 |
$4K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
972 |
904 |
$4K |
| 71045 |
Radiologic examination, chest; single view |
4,173 |
3,340 |
$3K |
| 80050 |
General health panel |
13 |
13 |
$3K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
1,249 |
707 |
$3K |
| 97162 |
|
90 |
77 |
$2K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
56 |
39 |
$2K |
| 85610 |
|
4,431 |
3,654 |
$2K |
| 83880 |
|
1,643 |
1,280 |
$2K |
| 80305 |
|
1,644 |
1,437 |
$2K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
4,817 |
3,861 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
5,124 |
2,403 |
$1K |
| 80061 |
Lipid panel |
2,495 |
2,326 |
$1K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,898 |
2,642 |
$1K |
| 0013A |
|
32 |
31 |
$1K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
34 |
31 |
$923.70 |
| 82607 |
|
433 |
389 |
$903.38 |
| 86403 |
|
594 |
540 |
$746.95 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,694 |
1,550 |
$715.21 |
| 73564 |
|
20 |
12 |
$714.64 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
4,450 |
3,528 |
$706.31 |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
14 |
12 |
$689.81 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
841 |
795 |
$611.53 |
| 73130 |
|
29 |
25 |
$587.72 |
| 73610 |
|
69 |
64 |
$564.38 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
255 |
24 |
$459.88 |
| 82728 |
|
333 |
290 |
$436.55 |
| 82803 |
|
411 |
286 |
$429.98 |
| 81025 |
|
758 |
713 |
$380.76 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,010 |
741 |
$354.91 |
| 96376 |
|
659 |
479 |
$345.04 |
| 84484 |
|
4,966 |
3,434 |
$317.85 |
| 87400 |
|
451 |
211 |
$302.97 |
| 90715 |
|
28 |
25 |
$281.81 |
| 87088 |
|
901 |
760 |
$274.21 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
1,170 |
1,100 |
$245.78 |
| 81003 |
|
2,065 |
1,844 |
$208.74 |
| 81001 |
|
4,898 |
4,030 |
$200.92 |
| 82043 |
|
175 |
172 |
$200.61 |
| 85730 |
|
2,291 |
1,962 |
$196.44 |
| A9270 |
Non-covered item or service |
5,492 |
3,078 |
$184.50 |
| 83020 |
|
1,272 |
1,012 |
$181.04 |
| 83735 |
|
2,890 |
2,176 |
$168.35 |
| 83690 |
|
3,035 |
2,525 |
$161.51 |
| 84703 |
|
903 |
841 |
$154.98 |
| 83605 |
|
3,473 |
2,541 |
$131.90 |
| 87081 |
|
29 |
28 |
$114.59 |
| 80299 |
|
224 |
187 |
$80.85 |
| 85651 |
|
498 |
444 |
$77.99 |
| 36415 |
Collection of venous blood by venipuncture |
17,643 |
13,196 |
$68.46 |
| 99001 |
|
41 |
40 |
$58.20 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
5,490 |
3,614 |
$54.12 |
| 85379 |
|
718 |
586 |
$54.10 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
179 |
151 |
$50.00 |
| 84481 |
|
68 |
60 |
$40.34 |
| 83540 |
|
354 |
314 |
$39.66 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
12 |
12 |
$38.21 |
| 87040 |
|
1,483 |
800 |
$30.02 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
524 |
502 |
$28.74 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
4,124 |
2,557 |
$25.25 |
| 84145 |
|
191 |
167 |
$24.31 |
| J7050 |
Infusion, normal saline solution, 250 cc |
1,480 |
881 |
$23.47 |
| 82550 |
|
497 |
416 |
$18.88 |
| 80329 |
|
171 |
95 |
$17.24 |
| 93040 |
|
152 |
129 |
$16.58 |
| 87186 |
|
1,253 |
1,048 |
$13.84 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
4,046 |
2,698 |
$13.08 |
| 82962 |
|
61 |
48 |
$12.96 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,910 |
1,085 |
$12.78 |
| 86756 |
|
224 |
217 |
$12.68 |
| 73080 |
|
15 |
14 |
$12.54 |
| 82570 |
|
75 |
68 |
$9.64 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
949 |
667 |
$0.63 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
38 |
12 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
51 |
42 |
$0.00 |
| 97533 |
|
27 |
18 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
35 |
30 |
$0.00 |
| 73110 |
|
13 |
12 |
$0.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
14 |
13 |
$0.00 |
| 80076 |
|
14 |
12 |
$0.00 |
| 97164 |
|
21 |
15 |
$0.00 |
| 84156 |
|
14 |
14 |
$0.00 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
12 |
12 |
$0.00 |
| 83550 |
|
345 |
306 |
$0.00 |
| 86141 |
|
17 |
12 |
$0.00 |
| 36000 |
|
287 |
248 |
$0.00 |
| 82150 |
|
169 |
146 |
$0.00 |
| 86140 |
|
406 |
374 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
58 |
51 |
$0.00 |
| 82553 |
|
116 |
86 |
$0.00 |
| 87077 |
|
70 |
65 |
$0.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
136 |
78 |
$0.00 |
| 91301 |
|
213 |
184 |
$0.00 |
| 82746 |
|
126 |
112 |
$0.00 |
| J2060 |
Injection, lorazepam, 2 mg |
88 |
52 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
89 |
30 |
$0.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
40 |
29 |
$0.00 |
| 97014 |
|
28 |
12 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
29 |
26 |
$0.00 |